Quince Therapeutics registers up to 17.3M shares for resale by investors

* Quince Therapeutics (NASDAQ:QNCX [https://seekingalpha.com/symbol/QNCX]) has registered up to 17.34M shares of common stock for resale by selling stockholders.
* The registration includes 6.67M existing shares and up to 10.67M shares issuable upon exercise of warrants.
* Of the warrants, 2M are pre-funded and 8.67M are standard common stock warrants.
* The shares and warrants were originally purchased under a securities agreement dated June 12, 2025.
* Quince will not receive proceeds from resale, except if warrants are exercised for cash.
* Source: SEC filing [https://seekingalpha.com/filing/10222244]

MORE ON QUINCE THERAPEUTICS

* Quince Therapeutics: Data In Ataxia-Telangiectasia Scheduled For Early 2026 [https://seekingalpha.com/article/4787078-quince-therapeutics-data-in-ataxia-telangiectasia-scheduled-for-early-2026]
* Seeking Alpha’s Quant Rating on Quince Therapeutics [https://seekingalpha.com/symbol/QNCX/ratings/quant-ratings]
* Historical earnings data for Quince Therapeutics [https://seekingalpha.com/symbol/QNCX/earnings]
* Financial information for Quince Therapeutics [https://seekingalpha.com/symbol/QNCX/income-statement]